[
    "{\"step_by_step_thinking\": \"Based on the information provided in the relevant documents, rilonacept is approved by the FDA for the treatment of recurrent pericarditis. Multiple studies and clinical trials have shown that rilonacept is effective in reducing the risk of recurrent pericarditis, improving clinical response, and normalizing inflammatory markers. Therefore, the answer is A. yes.\", \"answer_choice\": \"A\"}"
]